65 filings
8-K
IDYA
Ideaya Biosciences Inc
12 Mar 24
IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer
6:04am
8-K
IDYA
Ideaya Biosciences Inc
20 Feb 24
IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023
6:07am
8-K
IDYA
Ideaya Biosciences Inc
23 Jan 24
Other Events
6:03am
8-K
IDYA
Ideaya Biosciences Inc
19 Jan 24
Entry into a Material Definitive Agreement
5:18pm
8-K
IDYA
Ideaya Biosciences Inc
16 Jan 24
Other Events
6:07am
8-K
0b3pqv4
12 Jan 24
Other Events
6:04am
8-K
yblzk2in913msfay
4 Dec 23
IDEAYA Announces Clinical Study Collaboration with Gilead Sciences to Evaluate Trodelvy® and IDE397 Combination in MTAP-Deletion Bladder Cancer
6:04am
8-K
3axx3ew
17 Nov 23
Entry into a Material Definitive Agreement
6:02am
8-K
0gy 7hmyd9g2t5pbi
7 Nov 23
IDEAYA Biosciences, Inc. Reports Third Quarter 2023
6:01am
8-K
xd6f0
27 Oct 23
Other Events
4:23pm
8-K
9a3kh7rwpwjci8va
24 Oct 23
Results of Operations and Financial Condition
4:21pm
8-K
5alvdy98cp7b0 miw
23 Oct 23
Other Events
8:09am
8-K
wip yi1bx1
26 Sep 23
Departure of Directors or Certain Officers
6:05am
8-K
154vg 7yqkuai8m
10 Aug 23
IDEAYA Biosciences, Inc. Reports Second Quarter 2023
6:01am
8-K
o9xf8yie4nxdo2
3 Jul 23
Departure of Directors or Certain Officers
4:01pm
8-K
1hslxx6r33 1u9
30 Jun 23
Entry into a Material Definitive Agreement
4:01pm
8-K
0idgm7mef6ln1 k3ekt
9 Jun 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
g4dtwin2jmymj lp
6 Jun 23
Entry into a Material Definitive Agreement
6:02am
8-K
b71 tasjc9
16 May 23
IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer
6:02am
8-K
act2gj9q
9 May 23
IDEAYA Biosciences, Inc. Reports First Quarter 2023 Financial Results
6:01am